D'Onofrio, Raffaella
D'Onofrio, Raffaella
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting
2023 D'Onofrio, Raffaella; Omarini, Claudia; Toss, Angela; Sperduti, Isabella; Piacentini, Federico; Barbolini, Monica; Cortesi, Laura; Barbieri, Elena; Pettorelli, Elisa; Chiavelli, Chiara; Dominici, Massimo; Moscetti, Luca
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis
2021 D'Onofrio, R.; Piacentini, F.; Barbolini, M.; Isca, C.; Nasso, C.; Caggia, F.; Dominici, M.; Moscetti, L.; Omarini, C.
Axillary Ectopic Carcinoma of the Breast. Report of Two Cases with Different Clinical Presentation and Review of the Literature.
2019 D'Onofrio, Raffaella; Piacentini, Federico; Combi, Francesca; Omarini, Claudia; Luca, Moscetti; Antonella, Drago; Andreotti, Alessia; Rovesti, Giulia; Enza, Palma; Anna, Gambini; Papi, Simona; Tazzioli, Giovanni
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
2022 Del Re, M.; Crucitta, S.; Omarini, C.; Bargagna, I.; Mongillo, M.; Palleschi, M.; Stucci, S.; Meattini, I.; D'Onofrio, R.; Lorenzini, G.; Biondani, P.; De Giorgi, U.; Porta, C.; Livi, L.; Natalizio, S.; Fontana, A.; Giontella, E.; Angelini, L.; Fogli, S.; Danesi, R.
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice
2022 D’Onofrio, Raffaella; Caputo, Francesco; Prampolini, Francesco; Spallanzani, Andrea; Gelsomino, Fabio; Bettelli, Stefania; Manfredini, Samantha; Reggiani Bonetti, Luca; Carotenuto, Pietro; Bocconi, Alessandro; Dominici, Massimo; Luppi, Gabriele; Salati, Massimiliano
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials.
2019 Omarini, Claudia; Piacentini, Federico; Sperduti, Isabella; Barbolini, Monica; Isca, Chrystel; Nasso, Cecilia; Toss, Angela; D'Onofrio, Raffaella; Cortesi, Laura; Barbieri, Elena; Cascinu, Stefano; Moscetti, Luca
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery.
2020 Nasso, C.; Barbolini, M.; Isca, C.; D'Onofrio, R.; Cortesi, G.; Dominici, M.; Piacentini, F.; Omarini, C.
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis
2020 D'Onofrio, R.; Omarini, C.; Barbolini, M.; Nasso, C.; Isca, C.; Dominici, M.; Piacentini, F.
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis
2023 D'Onofrio, R.; Sperduti, I.; Piacentini, F.; Barbolini, M.; Omarini, C.; Toss, A.; Cortesi, L.; Barbieri, E.; Canino, F.; Dominici, M.; Moscetti, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting | 1-gen-2023 | D'Onofrio, Raffaella; Omarini, Claudia; Toss, Angela; Sperduti, Isabella; Piacentini, Federico; Barbolini, Monica; Cortesi, Laura; Barbieri, Elena; Pettorelli, Elisa; Chiavelli, Chiara; Dominici, Massimo; Moscetti, Luca | |
| Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis | 1-gen-2021 | D'Onofrio, R.; Piacentini, F.; Barbolini, M.; Isca, C.; Nasso, C.; Caggia, F.; Dominici, M.; Moscetti, L.; Omarini, C. | |
| Axillary Ectopic Carcinoma of the Breast. Report of Two Cases with Different Clinical Presentation and Review of the Literature. | 1-gen-2019 | D'Onofrio, Raffaella; Piacentini, Federico; Combi, Francesca; Omarini, Claudia; Luca, Moscetti; Antonella, Drago; Andreotti, Alessia; Rovesti, Giulia; Enza, Palma; Anna, Gambini; Papi, Simona; Tazzioli, Giovanni | |
| Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib | 1-gen-2022 | Del Re, M.; Crucitta, S.; Omarini, C.; Bargagna, I.; Mongillo, M.; Palleschi, M.; Stucci, S.; Meattini, I.; D'Onofrio, R.; Lorenzini, G.; Biondani, P.; De Giorgi, U.; Porta, C.; Livi, L.; Natalizio, S.; Fontana, A.; Giontella, E.; Angelini, L.; Fogli, S.; Danesi, R. | |
| CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice | 1-gen-2022 | D’Onofrio, Raffaella; Caputo, Francesco; Prampolini, Francesco; Spallanzani, Andrea; Gelsomino, Fabio; Bettelli, Stefania; Manfredini, Samantha; Reggiani Bonetti, Luca; Carotenuto, Pietro; Bocconi, Alessandro; Dominici, Massimo; Luppi, Gabriele; Salati, Massimiliano | |
| Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. | 1-gen-2019 | Omarini, Claudia; Piacentini, Federico; Sperduti, Isabella; Barbolini, Monica; Isca, Chrystel; Nasso, Cecilia; Toss, Angela; D'Onofrio, Raffaella; Cortesi, Laura; Barbieri, Elena; Cascinu, Stefano; Moscetti, Luca | |
| Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. | 1-gen-2020 | Nasso, C.; Barbolini, M.; Isca, C.; D'Onofrio, R.; Cortesi, G.; Dominici, M.; Piacentini, F.; Omarini, C. | |
| PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis | 1-gen-2020 | D'Onofrio, R.; Omarini, C.; Barbolini, M.; Nasso, C.; Isca, C.; Dominici, M.; Piacentini, F. | |
| Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis | 1-gen-2023 | D'Onofrio, R.; Sperduti, I.; Piacentini, F.; Barbolini, M.; Omarini, C.; Toss, A.; Cortesi, L.; Barbieri, E.; Canino, F.; Dominici, M.; Moscetti, L. |